Louis Johann de Jager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Louis Johann de Jager has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Anna-Mart Engelbrecht
Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa
1 shared publication - Carla Eksteen
Department of Physiological Sciences, Faculty of Science, University of Stellenbosch, Stellenbosch 7602, South Africa
1 shared publication - Daniel Wilhelm Olivier
Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch 7600, Western Cape, South Africa
1 shared publication Diana Rufaro Jaravaza
Division of Anatomical Pathology, Stellenbosch University, National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa
1 shared publication- Etheresia Pretorius
Stellenbosch University, South Africa
1 shared publication - Frederick C. de Beer
Department of Internal Medicine, University of Kentucky, Lexington, KY 40536, USA
1 shared publication
Latest Publications
- Open Access
Inflammation and Tumor Progression: The Differential Impact of SAA in Breast Cancer Models
Background: Previous research has shown that the Serum Amyloid A (SAA) protein family is intricately involved in inflammatory signaling and various disease pathologies. We have previously demonstrated that SAA is associated with increased colitis disease severity and the promotion of tumorigenesis. However, the specific role of SAA proteins in breast cancer pathology remains unclear. Therefore, we investigated the role of systemic SAA1 and SAA2 (SAA1/2) in a triple-negative breast cancer mouse model. Methods: Syngeneic breast tumors were established in wild-type mice, and mice lacking the SAA1/2 (SAADKO). Subsequently, tumor volume was monitored, species survival determined, the inflammatory profiles of mice assessed with a multiplex assay, and tumor molecular biology and histology characterized with Western blotting and H&E histological staining. Results: WT tumor-bearing mice had increased levels of plasma SAA compared to wild-type control mice, while SAADKO control and tumor-bearing mice presented with lower levels of SAA in their plasma. SAADKO tumor-bearing mice also displayed significantly lower concentrations of systemic inflammatory markers. Tumors from SAADKO mice overall had lower levels of SAA compared to tumors from wild-type mice, decreased apoptosis and inflammasome signaling, and little to no tumor necrosis. Conclusions: We demonstrated that systemic SAA1/2 stimulates the activation of the NLRP3 inflammasome in breast tumors, leading to the production of pro-inflammatory cytokines. This, in turn, promoted apoptosis and tumor necrosis but did not significantly impact tumor growth or histological grading.
Open AccessInflammation and Tumor Progression: The Differential Impact of SAA in Breast Cancer Models
Background: Previous research has shown that the Serum Amyloid A (SAA) protein family is intricately involved in inflammatory signaling and various disease pathologies. We have previously demonstrated that SAA is associated with increased colitis disease severity and the promotion of tumorigenesis. However, the specific role of SAA proteins in breast cancer pathology remains unclear. Therefore, we investigated the role of systemic SAA1 and SAA2 (SAA1/2) in a triple-negative breast cancer mouse model. Methods: Syngeneic breast tumors were established in wild-type mice, and mice lacking the SAA1/2 (SAADKO). Subsequently, tumor volume was monitored, species survival determined, the inflammatory profiles of mice assessed with a multiplex assay, and tumor molecular biology and histology characterized with Western blotting and H&E histological staining. Results: WT tumor-bearing mice had increased levels of plasma SAA compared to wild-type control mice, while SAADKO control and tumor-bearing mice presented with lower levels of SAA in their plasma. SAADKO tumor-bearing mice also displayed significantly lower concentrations of systemic inflammatory markers. Tumors from SAADKO mice overall had lower levels of SAA compared to tumors from wild-type mice, decreased apoptosis and inflammasome signaling, and little to no tumor necrosis. Conclusions: We demonstrated that systemic SAA1/2 stimulates the activation of the NLRP3 inflammasome in breast tumors, leading to the production of pro-inflammatory cytokines. This, in turn, promoted apoptosis and tumor necrosis but did not significantly impact tumor growth or histological grading.
- Open Access
- 2 April 2021
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 22, e931437-e931437-8
Unusual Presentation of Atrial Myxoma: A Case Report and Review of the Literature
Unusual Presentation of Atrial Myxoma: A Case Report and Review of the Literature - Article abstract #931437
- 2 April 2021
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 22, e931437-e931437-8
Open AccessUnusual Presentation of Atrial Myxoma: A Case Report and Review of the Literature
Unusual Presentation of Atrial Myxoma: A Case Report and Review of the Literature - Article abstract #931437